34 results on '"Deichmann, Annette"'
Search Results
2. Cell Cycle Status of CD34+ Hemopoietic Stem Cells Determines Lentiviral Integration in Actively Transcribed and Development-related Genes
3. Cloning Vectors
4. Insertion Sites in Engrafted Cells Cluster Within a Limited Repertoire of Genomic Areas After Gammaretroviral Vector Gene Therapy
5. The LAM-PCR Method to Sequence LV Integration Sites
6. Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo
7. Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy
8. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1
9. The Clonal Activity of Marked Hematopoietic Stem Cells
10. Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis
11. Cell Cycle Status of CD34+Hemopoietic Stem Cells Determines Lentiviral Integration in Actively Transcribed and Development-related Genes
12. Mutations in ROGDI Cause Kohlschütter-Tönz Syndrome
13. Preclinical Evaluation of Efficacy and Safety of an Improved Lentiviral Vector for the Treatment of β-Thalassemia and Sickle Cell Disease
14. Vector Integration and Tumorigenesis
15. The LAM-PCR Method to Sequence LV Integration Sites.
16. Biosafety Considerations Using Gamma-Retroviral Vectors in Gene Therapy
17. Parallel assessment of globin lentiviral transfer in induced pluripotent stem cells and adult hematopoietic stem cells derived from the same transplanted β-thalassemia patient
18. Bioinformatic Clonality Analysis of Next-Generation Sequencing-Derived Viral Vector Integration Sites
19. Analyzing the Number of Common Integration Sites of Viral Vectors – New Methods and Computer Programs
20. Comprehensive genomic access to vector integration in clinical gene therapy
21. Comprehensive and Unbiased Integration Site Analysis in Clinical Gene Therapy.
22. The gene corrected clonal inventory in clinical gene therapy trials
23. The clonal fate of gene corrected myelo- and lymphopoiesis
24. The Clonal Inventory of Gene Corrected Hematopoiesis in Three Successful Clinical Gene Therapy Trials
25. Real-Time Definition of Non-Randomness in the Distribution of Genomic Events
26. Non-Random Integration and Clone Selection by Lentiviral SIN-LTR Vectors.
27. Insertional Activation of MDS1/EVI1, PRDM16 and SETBP1 in a Successful Chronic Granulomatous Disease (CGD) Gene Therapy Trial.
28. 723. In Vivo Expansion of MDS1/EVI1, PRDM16 and SETBP1 Integration Clones in Successful Chronic Granulomatous Disease (CGD) Gene Therapy Trial
29. Myeloid Expansion after Insertional Activation of MDS1/EVI1, PRDM16 and SETBP1 in a Successful Chronic Granulomatous Gene Therapy Trial.
30. Sustained Polyclonal Hematopoietic Repopulation after Successful SCID-X1 Gene Therapy by Means of a Non Random Integrating Pseudotyped Gammaretrovector.
31. Biosafety Considerations Using Gamma-Retroviral Vectors in Gene Therapy
32. Preclinical Evaluation of Efficacy and Safety of an Improved Lentiviral Vector for the Treatment of β-Thalassemia and Sickle Cell Disease
33. 1076. Stable Polyclonal Hematopoietic Repopulation after Successful Clinical Gene Therapy of Chronic Granulomatous Disease (CGD)
34. 33. Non-Random Genomic Distribution of Retrovirus Vector Integration in Successful SCID-X1 Gene Therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.